Imago Biosciences Inc (IMGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 11,226 | 19,266 | 4,961 | N/A |
| Marketable Securities | 206,184 | 57,375 | 2,741 | N/A |
| TOTAL | $221,304 | $77,822 | $8,490 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 2 | 8 | N/A | N/A |
| Investments And Advances | 0 | 19,689 | 0 | 0 |
| Other Non-Current Assets | 3,480 | 1,414 | 11 | 0 |
| TOTAL | $3,482 | $21,111 | $11 | $N/A |
| Total Assets | $224,786 | $98,933 | $8,501 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 3,459 | 1,379 | 1,371 | 0 |
| Accrued Expenses | 6,633 | 3,726 | 1,266 | N/A |
| TOTAL | $10,092 | $5,105 | $2,637 | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 162,612 | 57,266 | 0 |
| TOTAL | $N/A | $162,612 | $57,266 | $N/A |
| Total Liabilities | $10,092 | $167,717 | $59,903 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 33,707 | N/A | N/A | N/A |
| Common Shares | 3 | N/A | N/A | N/A |
| Retained earnings | -112,653 | -70,342 | -52,509 | N/A |
| Other shareholders' equity | -43 | -3 | 1 | 0 |
| TOTAL | $214,694 | $-68,784 | $-51,402 | $N/A |
| Total Liabilities And Equity | $224,786 | $98,933 | $8,501 | $0 |